United Therapeutics Corporation is a company in the U.S. stock market and it is a holding in 150 U.S.-traded ETFs. UTHR has around 6.1M shares in the U.S. ETF market. The largest ETF holder of UTHR is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.20M shares. Investors may also find of interest that the ETF with the largest allocation to UTHR stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 8.60%. On average, U.S. ETFs allocate 0.48% of UTHR to their portfolios.
Additionally, UTHR is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with UTHR as a holding is the iShares Morningstar Value ETF (ILCV), with a return of 169.62%.